Clinical trials recruiting for Advanced Non-small Cell Lung Cancer (NSCLC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AK112 | 1 |
| AK112 Injection | 1 |
| AK146D1 for injection | 1 |
| AMT-116 | 1 |
| Administration of Vorolanib | 1 |
| BC008-1A 1200mg | 1 |
| BC008-1A 900mg | 1 |
| Osimertinib | 1 |
| Platinum chemotherapy | 1 |
Self-screener
Recruiting trials
- A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer
- AMT-116 in Combination With AK112 in Patients With Lung Cancer
- Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
- Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway
- Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
- Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
Related conditions
Trials recruiting for Advanced Non-small Cell Lung Cancer (NSCLC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced Non-small Cell Lung Cancer (NSCLC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.